-
Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M, Kaji H, Shinoda T, Hisanaga S, Ueda K, 2002: Tubulin seeds alphα-synuclein fibril formation[J]. J Biol Chem, 277, 2112-2117. doi: 10.1074/jbc.M102981200
-
Allinson TM, Parkin ET, Turner AJ, Hooper NM, 2003: ADAMs family members as amyloid precursor protein alpha-secretases[J]. J Neurosci Res, 74, 342-352. doi: 10.1002/jnr.10737
-
Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K, 1997: Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau[J]. Proc Natl Acad Sci USA, 94, 298-303. doi: 10.1073/pnas.94.1.298
-
Armstrong RA, Lantos PL, Cairns NJ, 2005: Overlap between neurodegenerative disorders[J]. Neuropathology, 25, 111-124. doi: 10.1111/j.1440-1789.2005.00605.x
-
Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, Chiesa R, Gobbi M, Salmona M, Forloni G, 2010: Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein[J]. Proc Natl Acad Sci USA, 107, 2295-2300. doi: 10.1073/pnas.0911829107
-
Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP, 1998: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain[J]. Med Microbiol Immunol, 187, 23-42. doi: 10.1007/s004300050071
-
Ball MJ, 1980: Features of Creutzfeldt-Jakob disease in brains of patients with familial dementia of Alzheimer type[J]. Can J Neurol Sci, 7, 51-57.
-
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E, 2011: Alzheimer's disease[J]. Lancet, 377, 1019-1031. doi: 10.1016/S0140-6736(10)61349-9
-
Ballatore C, Lee VM, Trojanowski JQ, 2007: Tau-mediated neurodegeneration in Alzheimer's disease and related disorders[J]. Nat Rev Neurosci, 8, 663-672. doi: 10.1038/nrn2194
-
Banks WA, Niehoff ML, Drago D, Zatta P, 2006: Aluminum complexing enhances amyloid beta protein penetration of blood-brain barrier[J]. Brain Res, 1116, 215-221. doi: 10.1016/j.brainres.2006.07.112
-
Barry AE, Klyubin I, Mc Donald JM, Mably AJ, Farrell MA, Scott M, Walsh DM, Rowan MJ, 2011: Alzheimer's disease brain-derived amyloid-beta-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein[J]. J Neurosci, 31, 7259-7263. doi: 10.1523/JNEUROSCI.6500-10.2011
-
Basler K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF, McKinley MP, Prusiner SB, Weissmann C, 1986: Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene[J]. Cell, 46, 417-428. doi: 10.1016/0092-8674(86)90662-8
-
Bate C, Williams A, 2011: Amyloid-beta-induced synapse damage is mediated via cross-linkage of cellular prion proteins[J]. J Biol Chem, 286, 37955-37963. doi: 10.1074/jbc.M111.248724
-
Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM, Salloway S, Sperling RA, Windisch M, Xiong C, 2011: Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease[J]. Alzheimers Res Ther, 3, 1-.
-
Bekris LM, Yu CE, Bird TD, Tsuang DW, 2010: Genetics of Alzheimer disease[J]. J Geriatr Psychiatry Neurol, 23, 213-227. doi: 10.1177/0891988710383571
-
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE, 2007: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database[J]. Nat Genet, 39, 17-23. doi: 10.1038/ng1934
-
Beyer K, 2006: Alphα-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers[J]. Acta Neuropathol, 112, 237-251. doi: 10.1007/s00401-006-0104-6
-
Bi R, Zhang W, Zhang DF, Xu M, Fan Y, Hu QX, Jiang HY, Tan L, Li T, Fang Y, Zhang C, Yao YG, 2018: Genetic association of the cytochrome c oxidase-related genes with Alzheimer's disease in Han Chinese[J]. Neuropsychopharmacology, 43, 2264-2276. doi: 10.1038/s41386-018-0144-3
-
Billingsley ML, Kincaid RL, 1997: Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration[J]. Biochem J, 323, 577-591. doi: 10.1042/bj3230577
-
Bird TD, 2008: Genetic aspects of Alzheimer disease[J]. Genet Med, 10, 231-239. doi: 10.1097/GIM.0b013e31816b64dc
-
Blennow K, de Leon MJ, Zetterberg H, 2006: Alzheimer's disease[J]. Lancet, 368, 387-403. doi: 10.1016/S0140-6736(06)69113-7
-
Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, Zatta P, 2011: Aluminum, copper, iron and zinc differentially alter amyloid-Abeta(1-42) aggregation and toxicity[J]. Int J Biochem Cell Biol, 43, 877-885. doi: 10.1016/j.biocel.2011.02.009
-
Brickell KL, Steinbart EJ, Rumbaugh M, Payami H, Schellenberg GD, Van Deerlin V, Yuan W, Bird TD, 2006: Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease[J]. Arch Neurol, 63, 1307-1311. doi: 10.1001/archneur.63.9.1307
-
Brown P, Salazar AM, Gibbs CJ Jr, Gajdusek DC, 1982: Alzheimer's disease and transmissible virus dementia (Creutzfeldt-Jakob disease)[J]. Ann N Y Acad Sci, 396, 131-143. doi: 10.1111/j.1749-6632.1982.tb26849.x
-
Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR, 2000: Tau protein isoforms, phosphorylation and role in neurodegenerative disorders[J]. Brain Res Brain Res Rev, 33, 95-130. doi: 10.1016/S0165-0173(00)00019-9
-
Burre J, Sharma M, Sudhof TC, 2012: Systematic mutagenesis of alphα-synuclein reveals distinct sequence requirements for physiological and pathological activities[J]. J Neurosci, 32, 15227-15242. doi: 10.1523/JNEUROSCI.3545-12.2012
-
Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, Falsig J, Mansuy IM, Aguzzi A, 2010: Prion protein and Abeta-related synaptic toxicity impairment[J]. EMBO Mol Med, 2, 306-314. doi: 10.1002/emmm.201000082
-
Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, ClergetDarpoux F, Brice A, Frebourg T, 1999: Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum[J]. Am J Hum Genet, 65, 664-670. doi: 10.1086/302553
-
Carbone I, Lazzarotto T, Ianni M, Porcellini E, Forti P, Masliah E, Gabrielli L, Licastro F, 2014: Herpes virus in Alzheimer's disease: relation to progression of the disease[J]. Neurobiol Aging, 35, 122-129. doi: 10.1016/j.neurobiolaging.2013.06.024
-
Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG, 2010: Replication of CLU, CR30, and PICALM associations with alzheimer disease[J]. Arch Neurol, 67, 961-964.
-
Castillo GM, Lukito W, Wight TN, Snow AD, 1999: The sulfate moieties of glycosaminoglycans are critical for the enhancement of beta-amyloid protein fibril formation[J]. J Neurochem, 72, 1681-1687.
-
Cataldo JK, Prochaska JJ, Glantz SA, 2010: Cigarette smoking is a risk factor for Alzheimer's disease: an analysis controlling for tobacco industry affiliation[J]. J Alzheimers Dis, 19, 465-480. doi: 10.3233/JAD-2010-1240
-
Chandra S, Chen X, Rizo J, Jahn R, Sudhof TC, 2003: A broken alpha-helix in folded alphα-Synuclein[J]. J Biol Chem, 278, 15313-15318. doi: 10.1074/jbc.M213128200
-
Chandra S, Gallardo G, Fernandez-Chacon R, Schluter OM, Sudhof TC, 2005: Alphα-synuclein cooperates with CSPalpha in preventing neurodegeneration[J]. Cell, 123, 383-396. doi: 10.1016/j.cell.2005.09.028
-
Chen S, Yadav SP, Surewicz WK, 2010: Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues[J]. J Biol Chem, 285, 26377-26383. doi: 10.1074/jbc.M110.145516
-
Chene G, Beiser A, Au R, Preis SR, Wolf PA, Dufouil C, Seshadri S, 2015: Gender and incidence of dementia in the Framingham Heart Study from mid-adult life[J]. Alzheimers Dement, 11, 310-320. doi: 10.1016/j.jalz.2013.10.005
-
Chin J, Palop JJ, Puolivali J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, Mucke L, 2005: Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease[J]. J Neurosci, 25, 9694-9703. doi: 10.1523/JNEUROSCI.2980-05.2005
-
Chouraki V, Seshadri S, 2014: Genetics of Alzheimer's disease[J]. Adv Genet, 87, 245-294. doi: 10.1016/B978-0-12-800149-3.00005-6
-
Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T, 2010: Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse[J]. BMC Neurosci, 11, 130-. doi: 10.1186/1471-2202-11-130
-
Clayton DF, George JM, 1998: The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease[J]. Trends Neurosci, 21, 249-254. doi: 10.1016/S0166-2236(97)01213-7
-
Cleobury JF, Skinner GR, Thouless ME, Wildy P, 1971: Association between psychopathic disorder and serum antibody to herpes simplex virus (type 1)[J]. Br Med J, 1, 438-439. doi: 10.1136/bmj.1.5746.438
-
Cleveland DW, Hwo SY, Kirschner MW, 1977: Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin[J]. J Mol Biol, 116, 207-225. doi: 10.1016/0022-2836(77)90213-3
-
Cook RH, Austin JH, 1978: Precautions in familial transmissible dementia: including familial Alzheimer's disease[J]. Arch Neurol, 35, 697-698. doi: 10.1001/archneur.1978.00500350001001
-
Cooke SF, Bliss TV, 2006: Plasticity in the human central nervous system[J]. Brain, 129, 1659-1673. doi: 10.1093/brain/awl082
-
Corder E, Lannfelt L, Mulder M, 1998: Apolipoprotein E and herpes simplex virus 1 in Alzheimer's disease[J]. Lancet, 352, 1312-1313.
-
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K, Villa SE, Meechoovet HB, Gerber JD, Frost D, Benson HL, O'Reilly S, Chibnik LB, Shulman JM, Singleton AB, Craig DW, Van Keuren-Jensen KR, Dunckley T, Bennett DA, De Jager PL, Heward C, Hardy J, Reiman EM, Huentelman MJ, 2010: Association of CR46, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals[J]. Hum Mol Genet, 19, 3295-3301. doi: 10.1093/hmg/ddq221
-
de Almeida CJ, Chiarini LB, da Silva JP, E Silva PM, Martins MA, Linden R, 2005: The cellular prion protein modulates phagocytosis and inflammatory response[J]. J Leukoc Biol, 77, 238-246. doi: 10.1189/jlb.1103531
-
De Mario A, Castellani A, Peggion C, Massimino ML, Lim D, Hill AF, Sorgato MC, Bertoli A, 2015: The prion protein constitutively controls neuronal store-operated Ca2+ entry through Fyn kinase[J]. Front Cell Neurosci, 9, 416-.
-
Denaro FJ, Staub P, Colmer J, Freed DM, 2003: Coexistence of Alzheimer disease neuropathology with herpes simplex encephalitis[J]. Cell Mol Biol (Noisy-le-grand), 49, 1233-1240.
-
Ding T, Zhou X, Kouadir M, Shi F, Yang Y, Liu J, Wang M, Yin X, Yang L, Zhao D, 2013: Cellular prion protein participates in the regulation of inflammatory response and apoptosis in BV2 microglia during infection with Mycobacterium bovis[J]. J Mol Neurosci, 51, 118-126. doi: 10.1007/s12031-013-9962-2
-
Dittrich W, Bode L, Ludwig H, Kao M, Schneider K, 1989: Learning deficiencies in Borna disease virus-infected but clinically healthy rats[J]. Biol Psychiatry, 26, 818-828. doi: 10.1016/0006-3223(89)90122-4
-
Dohler F, Sepulveda-Falla D, Krasemann S, Altmeppen H, Schluter H, Hildebrand D, Zerr I, Matschke J, Glatzel M, 2014: High molecular mass assemblies of amyloid-beta oligomers bind prion protein in patients with Alzheimer's disease[J]. Brain, 137, 873-886. doi: 10.1093/brain/awt375
-
Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, Nguyen M, Haditsch U, Raha D, Griffin C, Holsinger LJ, ArastuKapur S, Kaba S, Lee A, Ryder MI, Potempa B, Mydel P, Hellvard A, Adamowicz K, Hasturk H, Walker GD, Reynolds EC, Faull RLM, Curtis MA, Dragunow M, Potempa J, 2019: Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors[J]. Sci Adv, 5, eaau3333-. doi: 10.1126/sciadv.aau3333
-
Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, Haass C, 2003: Reconstitution of gamma-secretase activity[J]. Nat Cell Biol, 5, 486-488. doi: 10.1038/ncb960
-
El Bitar F, Qadi N, Al Rajeh S, Majrashi A, Abdulaziz S, Majrashi N, Al Inizi M, Taher A, Al Tassan N, 2019: Genetic study of Alzheimer's disease in Saudi population[J]. J Alzheimers Dis, 67, 231-242. doi: 10.3233/JAD-180415
-
Falker C, Hartmann A, Guett I, Dohler F, Altmeppen H, Betzel C, Schubert R, Thurm D, Wegwitz F, Joshi P, Verderio C, Krasemann S, Glatzel M, 2016: Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity[J]. J Neurochem, 137, 88-100. doi: 10.1111/jnc.13514
-
Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, Borsello T, Gobbi M, Harris DA, 2013: An N-terminal fragment of the prion protein binds to amyloid-beta oligomers and inhibits their neurotoxicity in vivo[J]. J Biol Chem, 288, 7857-7866. doi: 10.1074/jbc.M112.423954
-
Gajdusek DC, 1994: Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses[J]. Mol Neurobiol, 8, 1-13. doi: 10.1007/BF02778003
-
Ganzinger KA, Narayan P, Qamar SS, Weimann L, Ranasinghe RT, Aguzzi A, Dobson CM, McColl J, St George-Hyslop P, Klenerman D, 2014: Single-molecule imaging reveals that small amyloid-beta1-42 oligomers interact with the cellular prion protein (PrP(C))[J]. ChemBioChem, 15, 2515-2521. doi: 10.1002/cbic.201402377
-
Gao Z, Zhang H, Hu F, Yang L, Yang X, Zhu Y, Sy MS, Li C, 2016: Glycan-deficient PrP stimulates VEGFR2 signaling via glycosaminoglycan[J]. Cell Signal, 28, 652-662. doi: 10.1016/j.cellsig.2016.03.010
-
Gao Z, Shi J, Cai L, Luo M, Wong BS, Dong X, Sy MS, Li C, 2019: Prion dimer is heterogenous and is modulated by multiple negative and positive motifs[J]. Biochem Biophys Res Commun, 509, 570-576. doi: 10.1016/j.bbrc.2018.12.113
-
George JM, Jin H, Woods WS, Clayton DF, 1995: Characterization of a novel protein regulated during the critical period for song learning in the zebra finch[J]. Neuron, 15, 361-372. doi: 10.1016/0896-6273(95)90040-3
-
Ghetti B, Piccardo P, Spillantini MG, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tateishi J, Seiler C, Frangione B, Bugiani O, Giaccone G, Prelli F, Goedert M, Dlouhy SR, Tagliavini F, 1996: Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP[J]. Proc Natl Acad Sci USA, 93, 744-748. doi: 10.1073/pnas.93.2.744
-
Gimbel DA, Nygaard HB, Coffey EE, Gunther EC, Lauren J, Gimbel ZA, Strittmatter SM, 2010: Memory impairment in transgenic Alzheimer mice requires cellular prion protein[J]. J Neurosci, 30, 6367-6374. doi: 10.1523/JNEUROSCI.0395-10.2010
-
Glenner GG, Wong CW, 1984: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein[J]. Biochem Biophys Res Commun, 120, 885-890. doi: 10.1016/S0006-291X(84)80190-4
-
Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A, 1988: Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau[J]. Proc Natl Acad Sci USA, 85, 4051-4055. doi: 10.1073/pnas.85.11.4051
-
Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA, 1989: Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease[J]. Neuron, 3, 519-526. doi: 10.1016/0896-6273(89)90210-9
-
Goldman JS, Hahn SE, Catania JW, Larusse-Eckert S, Butson MB, Rumbaugh M, Strecker MN, Roberts JS, Burke W, Mayeux R, Bird T, 2011: Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors[J]. Genet Med, 13, 597-. doi: 10.1097/GIM.0b013e31821d69b8
-
Gonsalves D, Jovanovic K, Da Costa Dias B, Weiss SF, 2012: Global Alzheimer Research Summit: basic and clinical research: present and future Alzheimer research[J]. Prion, 6, 7-10. doi: 10.4161/pri.6.1.18854
-
Gotz J, Chen F, van Dorpe J, Nitsch RM, 2001: Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils[J]. Science, 293, 1491-1495. doi: 10.1126/science.1062097
-
Gourdain P, Ballerini C, Nicot AB, Carnaud C, 2012: Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system[J]. J Neuroinflamm, 9, 25-. doi: 10.1186/1742-2094-9-25
-
Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, Riddle DM, Kwong LK, Xu Y, Trojanowski JQ, Lee VM, 2013: Distinct alphα-synuclein strains differentially promote tau inclusions in neurons[J]. Cell, 154, 103-117. doi: 10.1016/j.cell.2013.05.057
-
Haas LT, Kostylev MA, Strittmatter SM, 2014: Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5)[J]. J Biol Chem, 289, 28460-28477. doi: 10.1074/jbc.M114.584342
-
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA, 2001: Is the risk of developing Alzheimer's disease greater for women than for men?[J]. Am J Epidemiol, 153, 132-136. doi: 10.1093/aje/153.2.132
-
Hebert LE, Weuve J, Scherr PA, Evans DA, 2013: Alzheimer disease in the United States (2010-2050) estimated using the 2010 census[J]. Neurology, 80, 1778-1783. doi: 10.1212/WNL.0b013e31828726f5
-
Himmelhoch E, Latham O, Mc DC, 1947: Alzheimer's disease complicated by a terminal salmonella infection[J]. Med J Aust, 1, 701-703. doi: 10.5694/j.1326-5377.1947.tb94344.x
-
Holtzman DM, Herz J, Bu G, 2012: Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease[J]. Cold Spring Harb Perspect Med, 2, a006312-.
-
Hooli BV, Mohapatra G, Mattheisen M, Parrado AR, Roehr JT, Shen Y, Gusella JF, Moir R, Saunders AJ, Lange C, Tanzi RE, Bertram L, 2012: Role of common and rare APP DNA sequence variants in Alzheimer disease[J]. Neurology, 78, 1250-1257. doi: 10.1212/WNL.0b013e3182515972
-
Hu W, Nessler S, Hemmer B, Eagar TN, Kane LP, Leliveld SR, Muller-Schiffmann A, Gocke AR, Lovett-Racke A, Ben LH, Hussain RZ, Breil A, Elliott JL, Puttaparthi K, Cravens PD, Singh MP, Petsch B, Stitz L, Racke MK, Korth C, Stuve O, 2010: Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling[J]. Brain, 133, 375-388. doi: 10.1093/brain/awp298
-
Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, GrundkeIqbal I, 2005: Tau pathology in Alzheimer disease and other tauopathies[J]. Biochim Biophys Acta, 1739, 198-210. doi: 10.1016/j.bbadis.2004.09.008
-
Itzhaki RF, 2017: Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts[J]. Faseb j, 31, 3216-3226. doi: 10.1096/fj.201700360
-
Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA, 1997: Herpes simplex virus type 1 in brain and risk of Alzheimer's disease[J]. Lancet, 349, 241-244. doi: 10.1016/S0140-6736(96)10149-5
-
Iwai A, Masliah E, Yoshimoto M, Ge N, Flanagan L, de Silva HA, Kittel A, Saitoh T, 1995: The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system[J]. Neuron, 14, 467-475. doi: 10.1016/0896-6273(95)90302-X
-
Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ, 2010: Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade[J]. Lancet Neurol, 9, 119-128. doi: 10.1016/S1474-4422(09)70299-6
-
Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF, 1991: Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains[J]. J Med Virol, 33, 224-227. doi: 10.1002/jmv.1890330403
-
Jamieson GA, Maitland NJ, Wilcock GK, Yates CM, Itzhaki RF, 1992: Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type[J]. J Pathol, 167, 365-368. doi: 10.1002/path.1711670403
-
Jellinger KA, Attems J, 2010: Prevalence of dementia disorders in the oldest-old: an autopsy study[J]. Acta Neuropathol, 119, 421-433. doi: 10.1007/s00401-010-0654-5
-
Jones EM, Surewicz WK, 2005: Fibril conformation as the basis of species-and strain-dependent seeding specificity of mammalian prion amyloids[J]. Cell, 121, 63-72. doi: 10.1016/j.cell.2005.01.034
-
Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC, 2000: Evidence for seeding of betaamyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice[J]. J Neurosci, 20, 3606-3611. doi: 10.1523/JNEUROSCI.20-10-03606.2000
-
Kim J, 1997: Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil[J]. Mol Cells, 7, 78-83.
-
Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J, 2006: Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study[J]. Lancet Neurol, 5, 735-741. doi: 10.1016/S1474-4422(06)70537-3
-
Konturek PC, Bazela K, Kukharskyy V, Bauer M, Hahn EG, Schuppan D, 2005: Helicobacter pylori upregulates prion protein expression in gastric mucosa: a possible link to prion disease[J]. World J Gastroenterol, 11, 7651-7656. doi: 10.3748/wjg.v11.i48.7651
-
Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I, 1993: Microtubule-associated protein tau[J]. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem, 268, 24374-24384.
-
Kostylev MA, Kaufman AC, Nygaard HB, Patel P, Haas LT, Gunther EC, Vortmeyer A, Strittmatter SM, 2015: Prion-protein-interacting Amyloid-beta oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models[J]. J Biol Chem, 290, 17415-17438. doi: 10.1074/jbc.M115.643577
-
Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I, 2006: Relationship between Helicobacter pylori infection and Alzheimer disease[J]. Neurology, 66, 938-940. doi: 10.1212/01.wnl.0000203644.68059.5f
-
Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H, 2002: Mutations of the prion protein gene phenotypic spectrum[J]. J Neurol, 249, 1567-1582. doi: 10.1007/s00415-002-0896-9
-
Kruger J, Moilanen V, Majamaa K, Remes AM, 2012: Molecular genetic analysis of the APP, PSEN1, and PSEN2 genes in Finnish patients with early-onset Alzheimer disease and frontotemporal lobar degeneration[J]. Alzheimer Dis Assoc Disord, 26, 272-276. doi: 10.1097/WAD.0b013e318231e6c7
-
Kumar S, Rezaei-Ghaleh N, Terwel D, Thal DR, Richard M, Hoch M, Mc Donald JM, Wullner U, Glebov K, Heneka MT, Walsh DM, Zweckstetter M, Walter J, 2011: Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease[J]. EMBO J, 30, 2255-2265. doi: 10.1038/emboj.2011.138
-
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, GrenierBoley B, 2013: Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease[J]. Nat Genet, 45, 1452-1458. doi: 10.1038/ng.2802
-
Lane CA, Hardy J, Schott JM, 2018: Alzheimer's disease[J]. Eur J Neurol, 25, 59-70. doi: 10.1111/ene.13439
-
Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesne SE, 2012: The complex PrP(c)- Fyn couples human oligomeric Abeta with pathological tau changes in Alzheimer's disease[J]. J Neurosci, 32, 16857-16871a. doi: 10.1523/JNEUROSCI.1858-12.2012
-
Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM, 2009: Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers[J]. Nature, 457, 1128-1132. doi: 10.1038/nature07761
-
Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ, 1991: A68: a major subunit of paired helical filaments and derivatized forms of normal Tau[J]. Science, 251, 675-678. doi: 10.1126/science.1899488
-
Lee HJ, Choi C, Lee SJ, 2002: Membrane-bound alphα-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form[J]. J Biol Chem, 277, 671-678. doi: 10.1074/jbc.M107045200
-
Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF, 2002: Herpesviruses in brain and Alzheimer's disease[J]. J Pathol, 197, 395-402. doi: 10.1002/path.1127
-
Liu J, Zhao D, Liu C, Ding T, Yang L, Yin X, Zhou X, 2015: Prion protein participates in the protection of mice from lipopolysaccharide infection by regulating the inflammatory process[J]. J Mol Neurosci, 55, 279-287. doi: 10.1007/s12031-014-0319-2
-
Lovheim H, Gilthorpe J, Adolfsson R, Nilsson LG, Elgh F, 2015: Reactivated herpes simplex infection increases the risk of Alzheimer's disease[J]. Alzheimers Dement, 11, 593-599. doi: 10.1016/j.jalz.2014.04.522
-
Loy CT, Schofield PR, Turner AM, Kwok JB, 2014: Genetics of dementia[J]. Lancet, 383, 828-840. doi: 10.1016/S0140-6736(13)60630-3
-
Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, Mohs R, Pasinetti GM, 2000: Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia[J]. Arch Neurol, 57, 1153-1160. doi: 10.1001/archneur.57.8.1153
-
Lycke E, Norrby R, Roos BE, 1974: A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections[J]. Br J Psychiatry, 124, 273-279. doi: 10.1192/bjp.124.3.273
-
Mahley RW, Rall SC Jr, 2000: Apolipoprotein E: far more than a lipid transport protein[J]. Annu Rev Genom Hum Genet, 1, 507-537. doi: 10.1146/annurev.genom.1.1.507
-
Markesbery W, Ehmann W, 1993: Aluminum and Alzheimer's disease[J]. Clin Neurosci, 1, 212-218.
-
Maroteaux L, Campanelli JT, Scheller RH, 1988: Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal[J]. J Neurosci, 8, 2804-2815. doi: 10.1523/JNEUROSCI.08-08-02804.1988
-
Martin L, Latypova X, Wilson CM, Magnaudeix A, Perrin ML, Yardin C, Terro F, 2013: Tau protein kinases: involvement in Alzheimer's disease[J]. Ageing Res Rev, 12, 289-309. doi: 10.1016/j.arr.2012.06.003
-
Masters CL, Gajdusek DC, Gibbs CJ Jr, 1981: The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease[J]. Brain, 104, 535-558. doi: 10.1093/brain/104.3.535
-
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K, 1985: Amyloid plaque core protein in Alzheimer disease and Down syndrome[J]. Proc Natl Acad Sci USA, 82, 4245-4249. doi: 10.1073/pnas.82.12.4245
-
Matsuo ES, Shin RW, Billingsley ML, Van deVoorde A, O'Connor M, Trojanowski JQ, Lee VM, 1994: Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau[J]. Neuron, 13, 989-1002. doi: 10.1016/0896-6273(94)90264-X
-
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosen E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttila T, Wallin A, Jonhagen ME, Minthon L, Winblad B, Blennow K, 2009: CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment[J]. JAMA, 302, 385-393. doi: 10.1001/jama.2009.1064
-
Maurer K, Volk S, Gerbaldo H, 1997: Auguste D and Alzheimer's disease[J]. Lancet, 349, 1546-1549. doi: 10.1016/S0140-6736(96)10203-8
-
McLachlan DR, Fraser PE, Dalton AJ, 1992: Aluminium and the pathogenesis of Alzheimer's disease: a summary of evidence[J]. Ciba Found Symp, 169, 87-98. doi: 10.1002/9780470514306.ch6
-
McLean PJ, Kawamata H, Ribich S, Hyman BT, 2000: Membrane association and protein conformation of alphα-synuclein in intact neurons[J]. Effect of Parkinson's disease-linked mutations. J Biol Chem, 275, 8812-8816.
-
McNamara J, Murray TA, 2016: Connections between herpes simplex virus type 1 and Alzheimer's disease pathogenesis[J]. Curr Alzheimer Res, 13, 996-1005. doi: 10.2174/1567205013666160314150136
-
Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M, 2006: Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host[J]. Science, 313, 1781-1784. doi: 10.1126/science.1131864
-
Middleton PJ, Petric M, Kozak M, Rewcastle NB, McLachlan DR, 1980: Herpes-simplex viral genome and senile and presenile dementias of Alzheimer and Pick[J]. Lancet, 1, 1038-. doi: 10.1016/S0140-6736(80)91490-7
-
Mielke MM, Vemuri P, Rocca WA, 2014: Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences[J]. Clin Epidemiol, 6, 37-48.
-
Miklossy J, 1993: Alzheimer's disease—a spirochetosis?[J]. NeuroReport, 4, 841-848. doi: 10.1097/00001756-199307000-00002
-
Miklossy J, Kasas S, Janzer RC, Ardizzoni F, Van der Loos H, 1994: Further ultrastructural evidence that spirochaetes may play a role in the aetiology of Alzheimer's disease[J]. NeuroReport, 5, 1201-1204. doi: 10.1097/00001756-199406020-00010
-
Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, Reiss K, Darbinian N, Darekar P, Mihaly L, Khalili K, 2006: Betaamyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes[J]. Neurobiol Aging, 27, 228-236. doi: 10.1016/j.neurobiolaging.2005.01.018
-
Mirra SS, Anand R, Spira TJ, 1986: HTLV-Ⅲ/LAV infection of the central nervous system in a 57-year-old man with progressive dementia of unknown cause[J]. N Engl J Med, 314, 1191-1192. doi: 10.1056/NEJM198605013141815
-
Mollinedo F, Gajate C, 2015: Lipid rafts as major platforms for signaling regulation in cancer[J]. Adv Biol Regul, 57, 130-146. doi: 10.1016/j.jbior.2014.10.003
-
Moulton PV, Yang W, 2012: Air pollution, oxidative stress, and Alzheimer's disease[J]. J Environ Public Health, 2012, 472751-.
-
Mozar HN, Bal DG, Howard JT, 1987: Perspectives on the etiology of Alzheimer's disease[J]. JAMA, 257, 1503-1507. doi: 10.1001/jama.1987.03390110079031
-
Mukherjee S, Mez J, Trittschuh EH, Saykin AJ, Gibbons LE, Fardo DW, Wessels M, Bauman J, Moore M, Choi SE, Gross AL, Rich J, Louden DKN, Sanders RE, Grabowski TJ, Bird TD, McCurry SM, Snitz BE, Kamboh MI, Lopez OL, De Jager PL, Bennett DA, Keene CD, Larson EB, Crane PK (2018) Genetic data and cognitively defined late-onset Alzheimer's disease subgroups. Mol Psychiatry. https://doi.org/10.1038/s41380-018-0298-8
-
Muller WE, Pfeifer K, Forrest J, Rytik PG, Eremin VF, Popov SA, Schroder HC, 1992: Accumulation of transcripts coding for prion protein in human astrocytes during infection with human immunodeficiency virus[J]. Biochim Biophys Acta, 1139, 32-40. doi: 10.1016/0925-4439(92)90079-3
-
Oshima M, Azuma H, Suzutani T, Ikeda H, Okuno A, 2001: Direct and mononuclear cell mediated effects on interleukin 6 production by glioma cells in infection with herpes simplex virus type 1[J]. J Med Virol, 63, 252-258. doi: 10.1002/1096-9071(200103)63:3<252::AID-JMV1009>3.0.CO;2-E
-
Ow SY, Dunstan DE, 2014: A brief overview of amyloids and Alzheimer's disease[J]. Protein Sci, 23, 1315-1331. doi: 10.1002/pro.2524
-
Pammer J, Weninger W, Tschachler E, 1998: Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin diseases[J]. Am J Pathol, 153, 1353-1358. doi: 10.1016/S0002-9440(10)65720-3
-
Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS, 2002: Cellsurface prion protein interacts with glycosaminoglycans[J]. Biochem J, 368, 81-90. doi: 10.1042/bj20020773
-
Pan T, Chang B, Wong P, Li C, Li R, Kang SC, Robinson JD, Thompsett AR, Tein P, Yin S, Barnard G, McConnell I, Brown DR, Wisniewski T, Sy MS, 2005: An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates[J]. J Virol, 79, 12355-12364. doi: 10.1128/JVI.79.19.12355-12364.2005
-
Pantera B, Bini C, Cirri P, Paoli P, Camici G, Manao G, Caselli A, 2009: PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway[J]. J Neurochem, 110, 194-207. doi: 10.1111/j.1471-4159.2009.06123.x
-
Petit CS, Barreau F, Besnier L, Gandille P, Riveau B, Chateau D, Roy M, Berrebi D, Svrcek M, Cardot P, Rousset M, Clair C, Thenet S, 2012: Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease[J]. Gastroenterology, 143, 122-132.e115. doi: 10.1053/j.gastro.2012.03.029
-
Petkova AT, Leapman RD, Guo Z, Yau WM, Mattson MP, Tycko R, 2005: Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils[J]. Science, 307, 262-265. doi: 10.1126/science.1105850
-
Pohanka M, 2018: Oxidative stress in Alzheimer disease as a target for therapy[J]. Bratisl Lek Listy, 119, 535-543.
-
Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM, 2002: Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice[J]. Faseb j, 16, 1138-1140. doi: 10.1096/fj.02-0012fje
-
Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC, 2001: Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease[J]. Arch Neurol, 58, 1395-1402. doi: 10.1001/archneur.58.9.1395
-
Priola SA, Caughey B, Wehrly K, Chesebro B, 1995: A 60-kDa prion protein (PrP) with properties of both the normal and scrapieassociated forms of PrP[J]. J Biol Chem, 270, 3299-3305. doi: 10.1074/jbc.270.7.3299
-
Prusiner SB, 1998: Prions[J]. Proc Natl Acad Sci USA, 95, 13363-13383. doi: 10.1073/pnas.95.23.13363
-
Rambold AS, Muller V, Ron U, Ben-Tal N, Winklhofer KF, Tatzelt J, 2008: Stress-protective signalling of prion protein is corrupted by scrapie prions[J]. EMBO J, 27, 1974-1984. doi: 10.1038/emboj.2008.122
-
Rao S, Ghani M, Guo Z, Deming Y, Wang K, Sims R, Mao C, Yao Y, Cruchaga C, Stephan DA, Rogaeva E, 2018: An APOEindependent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk[J]. Neurobiol Aging, 66, 178.e171-178.e178.
-
Readhead B, Haure-Mirande JV, Funk CC, Richards MA, Shannon P, Haroutunian V, Sano M, Liang WS, Beckmann ND, Price ND, Reiman EM, Schadt EE, Ehrlich ME, Gandy S, Dudley JT, 2018: Multiscale analysis of independent Alzheimer's Cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus[J]. Neuron, 99, 64-82.e67. doi: 10.1016/j.neuron.2018.05.023
-
Reitz C, Mayeux R, 2014: Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers[J]. Biochem Pharmacol, 88, 640-651. doi: 10.1016/j.bcp.2013.12.024
-
Renvoize EB, Hambling MH, 1984: Cytomegalovirus infection and Alzheimer's disease[J]. Age Ageing, 13, 205-209. doi: 10.1093/ageing/13.4.205
-
Renvoize EB, Hambling MH, Pepper MD, Rajah SM, 1979: Possible association of Alzheimer's disease with HLA-BW15 and cytomegalovirus infection[J]. Lancet, 1, 1238-. doi: 10.1016/S0140-6736(79)91914-7
-
Riviere GR, Riviere KH, Smith KS, 2002: Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease[J]. Oral Microbiol Immunol, 17, 113-118. doi: 10.1046/j.0902-0055.2001.00100.x
-
Roses AD, 2006: On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease[J]. J Alzheimers Dis, 9, 361-366. doi: 10.3233/JAD-2006-9S340
-
Rushworth JV, Griffiths HH, Watt NT, Hooper NM, 2013: Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1[J]. J Biol Chem, 288, 8935-8951. doi: 10.1074/jbc.M112.400358
-
Sakono M, Zako T, 2010: Amyloid oligomers: formation and toxicity of Abeta oligomers[J]. FEBS J, 277, 1348-1358. doi: 10.1111/j.1742-4658.2010.07568.x
-
Sauder C, Wolfer DP, Lipp HP, Staeheli P, Hausmann J, 2001: Learning deficits in mice with persistent Borna disease virus infection of the CNS associated with elevated chemokine expression[J]. Behav Brain Res, 120, 189-201. doi: 10.1016/S0166-4328(00)00370-3
-
Schatzl HM, Da Costa M, Taylor L, Cohen FE, Prusiner SB, 1997: Prion protein gene variation among primates[J]. J Mol Biol, 265, 257-. doi: 10.1006/jmbi.1996.0791
-
Schott JM, 2015: Infection, inflammation and Alzheimer's disease[J]. Eur J Neurol, 22, 1503-1504. doi: 10.1111/ene.12522
-
Sequiera LW, Jennings LC, Carrasco LH, Lord MA, Curry A, Sutton RN, 1979: Detection of herpes-simplex viral genome in brain tissue[J]. Lancet, 2, 609-612. doi: 10.1016/S0140-6736(79)91667-2
-
Serretti A, Artioli P, Quartesan R, De Ronchi D, 2005: Genes involved in Alzheimer's disease, a survey of possible candidates[J]. J Alzheimers Dis, 7, 331-353. doi: 10.3233/JAD-2005-7410
-
Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB, 1997: Lifetime risk of dementia and Alzheimer's disease[J]. The impact of mortality on risk estimates in the Framingham Study. Neurology, 49, 1498-1504. doi: 10.1212/wnl.49.6.1498
-
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ, 2008: Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory[J]. Nat Med, 14, 837-842. doi: 10.1038/nm1782
-
Shin RW, Lee VM, Trojanowski JQ, 1995: Neurofibrillary pathology and aluminum in Alzheimer's disease[J]. Histol Histopathol, 10, 969-978. doi: 10.1007/BF01464329
-
Simons K, Toomre D, 2000: Lipid rafts and signal transduction[J]. Nat Rev Mol Cell Biol, 1, 31-39.
-
Sochocka M, Zwolinska K, Leszek J, 2017: The infectious etiology of Alzheimer's disease[J]. Curr Neuropharmacol, 15, 996-1009. doi: 10.2174/1570159X15666170313122937
-
Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M, 1997: Alphα-synuclein in Lewy bodies[J]. Nature, 388, 839-840. doi: 10.1038/42166
-
Spinney L, 2014: Alzheimer's disease: the forgetting gene[J]. Nature, 510, 26-28. doi: 10.1038/510026a
-
Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, Santa-Maria I, Zimmer M, Aubry S, Steele JW, Kahler DJ, Dranovsky A, Arancio O, Crary JF, Gandy S, Noggle SA, 2014: Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors[J]. PLoS ONE, 9, :e84547-. doi: 10.1371/journal.pone.0084547
-
Stohr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K, 2012: Purified and synthetic Alzheimer's amyloid beta (Abeta) prions[J]. Proc Natl Acad Sci USA, 109, 11025-11030. doi: 10.1073/pnas.1206555109
-
Stohr J, Condello C, Watts JC, Bloch L, Oehler A, Nick M, DeArmond SJ, Giles K, DeGrado WF, Prusiner SB, 2014: Distinct synthetic Abeta prion strains producing different amyloid deposits in bigenic mice[J]. Proc Natl Acad Sci USA, 111, 10329-10334. doi: 10.1073/pnas.1408968111
-
Taniguchi T, Kawamata T, Mukai H, Hasegawa H, Isagawa T, Yasuda M, Hashimoto T, Terashima A, Nakai M, Mori H, Ono Y, Tanaka C, 2001: Phosphorylation of tau is regulated by PKN[J]. J Biol Chem, 276, 10025-10031. doi: 10.1074/jbc.M007427200
-
Thomas SM, Brugge JS, 1997: Cellular functions regulated by Src family kinases[J]. Annu Rev Cell Dev Biol, 13, 513-609. doi: 10.1146/annurev.cellbio.13.1.513
-
Tomic JL, Pensalfini A, Head E, Glabe CG, 2009: Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction[J]. Neurobiol Dis, 35, 352-358. doi: 10.1016/j.nbd.2009.05.024
-
Trotta T, Porro C, Calvello R, Panaro MA, 2014: Biological role of Toll-like receptor-4 in the brain[J]. J Neuroimmunol, 268, 1-12. doi: 10.1016/j.jneuroim.2014.01.014
-
Tschampa HJ, Neumann M, Zerr I, Henkel K, Schroter A, SchulzSchaeffer WJ, Steinhoff BJ, Kretzschmar HA, Poser S, 2001: Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease[J]. J Neurol Neurosurg Psychiatry, 71, 33-39. doi: 10.1136/jnnp.71.1.33
-
Tsutsui S, Hahn JN, Johnson TA, Ali Z, Jirik FR, 2008: Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis[J]. Am J Pathol, 173, 1029-1041. doi: 10.2353/ajpath.2008.071062
-
Ueda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y, Saitoh T, 1993: Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease[J]. Proc Natl Acad Sci USA, 90, 11282-11286. doi: 10.1073/pnas.90.23.11282
-
Ueda K, Saitoh T, Mori H, 1994: Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid[J]. Biochem Biophys Res Commun, 205, 1366-1372. doi: 10.1006/bbrc.1994.2816
-
Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, Wisniewski T, Gunther EC, Strittmatter SM, 2012: Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons[J]. Nat Neurosci, 15, 1227-1235. doi: 10.1038/nn.3178
-
Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, Kerrisk ME, Vortmeyer A, Wisniewski T, Koleske AJ, Gunther EC, Nygaard HB, Strittmatter SM, 2013: Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer abeta oligomer bound to cellular prion protein[J]. Neuron, 79, 887-902. doi: 10.1016/j.neuron.2013.06.036
-
Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P, 2004: Differential diagnosis of 201 possible Creutzfeldt- Jakob disease patients[J]. J Neurol, 251, 298-304. doi: 10.1007/s00415-004-0311-9
-
Vassar R, 2004: BACE1: the beta-secretase enzyme in Alzheimer's disease[J]. J Mol Neurosci, 23, 105-114. doi: 10.1385/JMN:23:1-2:105
-
Veerhuis R, Van Breemen MJ, Hoozemans JM, Morbin M, Ouladhadj J, Tagliavini F, Eikelenboom P, 2003: Amyloid beta plaqueassociated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro[J]. Acta Neuropathol, 105, 135-144. doi: 10.1007/s00401-002-0624-7
-
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, 2016: Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015[J]. Lancet, 388, 1545-1602. doi: 10.1016/S0140-6736(16)31678-6
-
Wang HZ, Bi R, Hu QX, Xiang Q, Zhang C, Zhang DF, Zhang W, Ma X, Guo W, Deng W, Zhao L, Ni P, Li M, Fang Y, Li T, Yao YG, 2016: Validating GWAS-identified risk loci for Alzheimer's disease in Han Chinese populations[J]. Mol Neurobiol, 53, 379-390. doi: 10.1007/s12035-014-9015-z
-
Watson CP, 1979: Clinical similarity of Alzheimer and Creutzfeldt- Jakob disease[J]. Ann Neurol, 6, 368-369. doi: 10.1002/ana.410060415
-
Watts JC, Prusiner SB, 2018: beta-amyloid prions and the pathobiology of Alzheimer's disease[J]. Cold Spring Harb Perspect Med, 8, 023507-.
-
Watts JC, Condello C, Stohr J, Oehler A, Lee J, DeArmond SJ, Lannfelt L, Ingelsson M, Giles K, Prusiner SB, 2014: Serial propagation of distinct strains of Abeta prions from Alzheimer's disease patients[J]. Proc Natl Acad Sci USA, 111, 10323-10328. doi: 10.1073/pnas.1408900111
-
Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW, 1975: A protein factor essential for microtubule assembly[J]. Proc Natl Acad Sci USA, 72, 1858-1862. doi: 10.1073/pnas.72.5.1858
-
Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr, 1996: NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded[J]. Biochemistry, 35, 13709-13715. doi: 10.1021/bi961799n
-
Westman G, Blomberg J, Yun Z, Lannfelt L, Ingelsson M, Eriksson BM, 2017: Decreased HHV-6 IgG in Alzheimer's disease[J]. Front Neurol, 8, 40-.
-
Willingham S, Outeiro TF, DeVit MJ, Lindquist SL, Muchowski PJ, 2003: Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alphα-synuclein[J]. Science, 302, 1769-1772. doi: 10.1126/science.1090389
-
Wisniewski HM, Merz GS, Carp RI, 1984: Senile dementia of the Alzheimer type: possibility of infectious etiology in genetically susceptible individuals[J]. Acta Neurol Scand Suppl, 99, 91-97. doi: 10.1111/j.1600-0404.1984.tb05673.x
-
Wojtowicz WM, Farzan M, Joyal JL, Carter K, Babcock GJ, Israel DI, Sodroski J, Mirzabekov T, 2002: Stimulation of enveloped virus infection by beta-amyloid fibrils[J]. J Biol Chem, 277, 35019-35024. doi: 10.1074/jbc.M203518200
-
World Health Organization (WHO) (2003) WHO manual for surveillance of human transmissible spongiform encephalopathies, including variant Creutzfeldt-Jakob disease. World Health Organization, Geneva
-
Wozniak MA, Shipley SJ, Combrinck M, Wilcock GK, Itzhaki RF, 2005: Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients[J]. J Med Virol, 75, 300-306. doi: 10.1002/jmv.20271
-
Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB, 2007: Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation[J]. Neurosci Lett, 429, 95-100. doi: 10.1016/j.neulet.2007.09.077
-
Wu GR, Mu TC, Gao ZX, Wang J, Sy MS, Li CY, 2017: Prion protein is required for tumor necrosis factor alpha (TNFalpha)- triggered nuclear factor kappaB (NF-kappaB) signaling and cytokine production[J]. J Biol Chem, 292, 18747-18759. doi: 10.1074/jbc.M117.787283
-
Xia Y, Saitoh T, Ueda K, Tanaka S, Chen X, Hashimoto M, Hsu L, Conrad C, Sundsmo M, Yoshimoto M, Thal L, Katzman R, Masliah E, 2001: Characterization of the human alphα-synuclein gene: genomic structure, transcription start site, promoter region and polymorphisms[J]. J Alzheimers Dis, 3, 485-494. doi: 10.3233/JAD-2001-3508
-
Yang X, Zhang Y, Zhang L, He T, Zhang J, Li C, 2014: Prion protein and cancers[J]. Acta Biochim Biophys Sin (Shanghai), 46, 431-440. doi: 10.1093/abbs/gmu019
-
Yi CW, Wang LQ, Huang JJ, Pan K, Chen J, Liang Y, 2018: Glycosylation significantly inhibits the aggregation of human prion protein and decreases its cytotoxicity[J]. Sci Rep, 8, 12603-. doi: 10.1038/s41598-018-30770-6
-
Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Nakashima H, Yasuda M, Kitamura Y, Ueda K, Checler F, Kuroda S, 2002: NACP/alphα-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases[J]. Acta Neuropathol, 104, 637-648. doi: 10.1007/s00401-002-0596-7
-
You H, Tsutsui S, Hameed S, Kannanayakal TJ, Chen L, Xia P, Engbers JD, Lipton SA, Stys PK, Zamponi GW, 2012: Abeta neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors[J]. Proc Natl Acad Sci USA, 109, 1737-1742. doi: 10.1073/pnas.1110789109
-
Younan ND, Sarell CJ, Davies P, Brown DR, Viles JH, 2013: The cellular prion protein traps Alzheimer's Abeta in an oligomeric form and disassembles amyloid fibers[J]. Faseb j, 27, 1847-1858. doi: 10.1096/fj.12-222588
-
Younan ND, Chen KF, Rose RS, Crowther DC, Viles JH, 2018: Prion protein stabilizes amyloid-beta (Abeta) oligomers and enhances Abeta neurotoxicity in a Drosophila model of Alzheimer's disease[J]. J Biol Chem, 293, 13090-13099. doi: 10.1074/jbc.RA118.003319
-
Zatta P, Drago D, Bolognin S, Sensi SL, 2009: Alzheimer's disease, metal ions and metal homeostatic therapy[J]. Trends Pharmacol Sci, 30, 346-355. doi: 10.1016/j.tips.2009.05.002
-
Zheng L, Longfei J, Jing Y, Xinqing Z, Haiqing S, Haiyan L, Fen W, Xiumin D, Jianping J, 2008: PRNP mutations in a series of apparently sporadic neurodegenerative dementias in China[J]. Am J Med Genet B Neuropsychiatr Genet, 147, 938-944.